They can’t do that because they don’t know the assay results yet. They might have confidence based upon for example XRF readings, but as far as I know they can’t use these in negotiations with investors when they have not been released to market.
They can release the assay results to market and then shortly after issue a trading halt pending capital raise. If the assay results are really good it could give a CR at a premium. This is what I think is likely to happen in about 3 weeks time.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
26.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $89.85M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 10043 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 11152 | 2 |
View Market Depth
| Last trade - 09.37am 25/06/2025 (20 minute delay) ? |
| PTR (ASX) Chart |
Day chart unavailable